The role of H2S bioavailability in endothelial dysfunction
Wang, R; Szabo, C; Ichinose, F; et al.Ahmed, A; Whiteman, M; Papapetropoulos, A
Date: 9 June 2015
Journal
Trends in Pharmacological Sciences
Publisher
Elsevier
Publisher DOI
Related links
Abstract
Endothelial dysfunction (EDF) reflects pathophysiological changes in the phenotype and functions of endothelial cells that result from and/or contribute to a plethora of cardiovascular diseases. We review the role of hydrogen sulfide (H2S) in the pathogenesis of EDF, one of the fastest advancing research topics. Conventionally treated ...
Endothelial dysfunction (EDF) reflects pathophysiological changes in the phenotype and functions of endothelial cells that result from and/or contribute to a plethora of cardiovascular diseases. We review the role of hydrogen sulfide (H2S) in the pathogenesis of EDF, one of the fastest advancing research topics. Conventionally treated as an environment pollutant, H2S is also produced in endothelial cells and participates in the fine regulation of endothelial integrity and functions. Disturbed H2S bioavailability has been suggested to be a novel indicator of EDF progress and prognosis. EDF manifests in different forms in multiple pathologies, but therapeutics aimed at remedying altered H2S bioavailability may benefit all.
Institute of Biomedical & Clinical Science
Collections of Former Colleges
Item views 0
Full item downloads 0